Source link : https://newshealth.biz/health-news/fda-oks-perioperative-immunotherapy-for-head-and-neck-cancer/
(MedPage Today) — The FDA approved pembrolizumab (Keytruda) for patients with PD-L1-positive resectable locally advanced head and neck squamous cell carcinoma as neoadjuvant monotherapy, continued as adjuvant therapy plus radiotherapy with or… Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116058 Author : Publish date : 2025-06-13 14:51:00 Copyright for syndicated content belongs to the linked Source.
The post FDA OKs Perioperative Immunotherapy for Head and Neck Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-13 14:51:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8